Antibodies cofactor catalysis

The addition of cofactors to antibodies is a sure means to confer a catalytic activity to them insofar as this cofactor is responsible for the activity. Indeed for many enzymes, the interaction with cofactors such as thiamins, flavins, pyridoxal phosphate, and ions or metal complexes is absolutely essential for the catalysis. It is thus a question there of building a new biocatalyst with two partners the cofactor responsible for the catalytic activity, and the antibody which binds not only the cofactor but also the substrate that it positions in a specific way one with respect to the other, and can possibly take part in the catalysis thanks to some of its amino acids. 

Catalytic antibodies, predicted by Jencks in 1969 and first discovered in 1986, can now be raised against a wide variety of haptens covering nearly every reaction. Catalytic antibodies are regarded as the best enzyme mimics, with very good selectivity, but almost always their catalytic efficiency is by far insufficient. Some natural RNA molecules act as catalysts with intrinsic enzyme-like activity which permits them to catalyze chemical reactions in the complete absence of protein cofactors. In addition, ribozymes identified through in-vitro selection have extended the repertoire of RNA catalysis. This versatility has lent credence to the idea that RNA molecules may have been central to the early stages of life on Earth. 

Many other redox reactions are potentially amenable to antibody catalysis. For example, the chemistry of the P-450 cytochromes, including the hydroxylation of alkanes and the epoxidation of alkenes, can be mimicked with synthetic porphyrins. Incorporation of such molecules into antibody active sites could conceivably yield new catalysts that combine the intrinsic reactivity of the cofactor with the tailored selectivity of the binding pocket. Work is just beginning in this area, but preliminary studies with porphyrin haptens have yielded some interesting results.126-130 Novel redox chemistry can also be anticipated for antibodies containing metal ions, flavins, nicotinamide analogs, and other reactive moieties. 

Vitamins, cofactors, and metals have the potential to broaden the scope of antibody catalysis considerably. In addition to hydrolytic and redox reactions, they facilitate many complex functional group interconversions in natural enzymes.131 Pyridoxal, for example, plays a central role in amino acid metabolism. Among the reactions it makes possible are transaminations, decarboxylations, racemizations, and (3,y-eliminations. It is also essential for ethylene biosynthesis. Not surprisingly, then, several groups have sought to incorporate pyridoxal derivatives into antibody combining sites. 

Inspired by enzymatic mechanisms, several groups have attempted to obtain amidase antibodies by recruiting a metal cofactor for catalysis. Introduction of... 

Enzymes use nonpeptidyl catalytic auxiliaries termed cofactors to gain additional chemical functionality. These include metal ions, hemes, thiamine, flavins, and pyri-doxal. To expand the scope of antibody catalysis, the introduction of cofactors into an antibody-combining site could be a powerful tool to improve catalysis. The diversity of the immune response should allow one to use not only the natural cofactors but also a host of unnatural cofactors unavailable to enzymes. 

---